Carnitine balance in hemodialyzed patients

Area of Science:

• Biochemistry
• Nephrology
• Nutritional Science

Background:

• 1-Carnitine is essential for fatty acid metabolism.
• Hemodialysis is known to remove substances from the blood.
• The impact of hemodialysis on 1-carnitine levels requires further investigation.

Purpose of the Study:

• To quantify 1-carnitine levels in plasma, dialyzate, and muscle before and after hemodialysis.
• To investigate the source of plasma 1-carnitine loss during hemodialysis.
• To evaluate the efficacy of chronic 1-carnitine administration in hemodialysis patients.

Main Methods:

• Assay of 1-carnitine in plasma, dialyzate, and muscle tissue.
• Analysis of four patients undergoing regular hemodialysis.
• Comparison of carnitine concentrations between hemodialyzed patients and controls.

Main Results:

• Plasma 1-carnitine levels decreased post-hemodialysis, suggesting loss from extracellular fluid.
• Muscle 1-carnitine concentrations did not significantly differ between patients and controls.
• Chronic 1-carnitine supplementation maintained plasma levels but did not alter muscle concentrations.

Conclusions:

• Hemodialysis-induced plasma 1-carnitine depletion may stem from extracellular fluid.
• Muscle 1-carnitine stores appear unaffected by hemodialysis in the short term.
• Carnitine supplementation can mitigate plasma losses but does not appear to replete muscle stores in this context.